SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Sale of Stock, Consideration Received Per Transaction
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Sale of Stock, Consideration Received Per Transaction of $2.25 million as of 2024-02-07, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedPerTransaction · last filed 2025-02-26
- 2024-02-07: Sale of Stock, Consideration Received Per Transaction $2.25M.
| Period end | Sale of Stock, Consideration Received Per Transaction |
|---|---|
| 2024-02-07 | $2.25M 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |